Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients

Francesco Gaudio, Patrizio Mazza, Anna Mele, Giulia Palazzo, Angelo Michele Carella, Mario Delia, Giovanni Pisapia, Domenico Pastore, Nicola Cascavilla, Vincenzo Pavone, Giorgina Specchia

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences